In May the Global AMR R&D Hub called for tenders for the implementation of a study to determine the global market potentials for four prioritised products relevant for addressing AMR. The call closed on June 19, 2020.
It is encouraging to see the level of current investment and its breadth. With the continuing rise of antimicrobial resistance and implications cutting across all areas of medicine, investments are a necessary foundation for urgently needed progress. The Dynamic Dashboard will help funders in their future funding decisions. Some high-level summary of information from the Dynamic Dashboard can be found here.
31 March 2020: The link to the Dynamic Dashboard is here.
The Dashboard will continue to mature its data set, expand the funders captured, its countries represented and its scope to other areas of AMR R&D. Additional user-functionality will follow soon. In the coming months, further galleries of information will be added including product pipelines and incentives.
A user guide and background information of how the information was collected can be found here.
We thank all the organisations that have provided data and invite anyone who would like to submit data to contact us.
As of 27 March 2020 the Global AMR R&D Hub is on Twitter. If you would like to be informed on news and latest developments of the Global AMR R&D Hub you can follow us here.
10 March 2020: The Global AMR R&D Hub is delighted to announce its support for the expert team at Gesundheit Österreich GmbH (GÖG). GÖG will work together with 10 countries to explore existing health system tools which could be applied to new AMR-impacting technologies to improve the sustainability of the flow of new products for future generations. GÖG has an extensive global network and unique health system insights to conduct this work which we hope will begin to report by third quarter this year.
On December 19, 2019 the Secretariat of the Global AMR R&D Hub was presented at the STAR-IDAZ IRC Workshop on “AMR and the development of innovative alternatives to antibiotics (ATA)” in Bangkok (www.star-idaz.net), which took place adjacent to the 3rd International Symposium on Alternatives to Antibiotics (ATA2019, https://www.ars.usda.gov/alternativestoantibiotics).
Dr Ralf Sudbrak, Scientific Programme Officer at the Hub, was invited to participate in the newly formed working group on ATA which aims at the formulation of a global research agenda on the development of alternatives to antibiotics.
On December 16 – 18, 2019 the Secretariat of the Global AMR R&D Hub was presented at the 3rd International Symposium on Alternatives to Antibiotics (ATA2019, https://www.ars.usda.gov/alternativestoantibiotics/) in Bangkok, where alternative strategies to prevent and control animal diseases were discussed.
Dr Ralf Sudbrak, Scientific Programme Officer at the Hub, presented the progress about the “Developing a global dynamic dashboard as a one-stop shop for AMR related research and development in One Health Sectors”.
The Secretariat of the Global AMR R&D Hub had the pleasure of delivering one of the key note presentations at the Emerging Antimicrobials and Diagnostics in AMR 2019 symposium organised by AMR Insights in Amsterdam on November 19 and 20, 2019. The presentation held by Dr Jennie Hood, Scientific Programme Officer at the Hub, focused on the ambitions of the Global AMR R&D Hub’s Dynamic Dashboard and the results of the recent public consultation on the draft Collaboration Framework. A copy of the presentation is available here.
The Global AMR R&D Hub’s Board of Members met in Paris on October 31, 2019. The meeting was hosted by the French ministry of higher education, research and innovation. India has joined the Hub in September as the newest Member and the Food and Agriculture Organisation of the United Nations (FAO) has joined the Hub as an Observer. The representatives attended a face-to-face Board meeting of the Hub for the first time and were extended a special welcome. Expanding the membership of the Hub’s Board of Members is a standing agenda item and countries and non-governmental donor organisations interested in joining the Board will find the relevant information on how to join here.
The current activities of the Global AMR R&D Hub for developing the Dynamic Dashboard and launching it in Q1 2020 were discussed. The Expert Advisory Group for determining the market potential of interventions addressing AMR reported on their work. Professor Towse from the Office of Health Economics gave a presentation about the study “HTA and Payment Mechanisms for New Drugs to Tackle AMR” that was commissioned by Wellcome Trust.
On 30 October the Board had its first joint meeting with the Stakeholder Group of the Global AMR R&D Hub. The Stakeholder Group gave input to the work of the Hub and the evaluation framework was presented by the external contractor who has been recruited for this task.